Furthermore, in the case of antitumoral action, ANXA1 is involved in the inhibition of cell proliferation, promotion of apoptosis, and reduction of cell motility, as shown in breast cancer (triple negative) [55] and prostate cancer [56]. The gene discussed is ANXA1; the disease is prostate carcinoma.